Michael R. Hayden, Director at IONIS PHARMACEUTICALS INC (IONS), bought 20,000 shares at $53.38 ($1.1M) on 2026-07-30, disclosed to the SEC on 2026-07-31.
Seasonal purchase ($1.1M) by Director — this insider has traded IONS in July in at least three consecutive prior years. Pattern-driven, low signal.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.38 | 15,000 | $801K | 75.6% |
| 2 | $51.60 | 5,000 | $258K | 24.4% |
| Total | $52.94 avg | 20,000 | $1.1M | 100% |
| Filing → |
| IONS | BUY | 2025-05-02 | $478K | — | Filing → |
| IONS | BUY | 2024-12-26 | $272K | — | Filing → |
| ABCL | BUY | 2023-09-26 | $98K | — | Filing → |